Shenzhen Kangtai Biological Products Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Kangtai Biological Products has a total shareholder equity of CN¥9.6B and total debt of CN¥2.6B, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are CN¥15.0B and CN¥5.4B respectively. Shenzhen Kangtai Biological Products's EBIT is CN¥555.8M making its interest coverage ratio 118.2. It has cash and short-term investments of CN¥997.0M.
Key information
27.4%
Debt to equity ratio
CN¥2.63b
Debt
Interest coverage ratio | 118.2x |
Cash | CN¥996.96m |
Equity | CN¥9.62b |
Total liabilities | CN¥5.40b |
Total assets | CN¥15.02b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300601's short term assets (CN¥5.0B) exceed its short term liabilities (CN¥2.7B).
Long Term Liabilities: 300601's short term assets (CN¥5.0B) exceed its long term liabilities (CN¥2.7B).
Debt to Equity History and Analysis
Debt Level: 300601's net debt to equity ratio (17%) is considered satisfactory.
Reducing Debt: 300601's debt to equity ratio has increased from 20% to 27.4% over the past 5 years.
Debt Coverage: 300601's debt is well covered by operating cash flow (31.5%).
Interest Coverage: 300601's interest payments on its debt are well covered by EBIT (118.2x coverage).